Christian Gisselbrecht

Christian Gisselbrecht

UNVERIFIED PROFILE

Are you Christian Gisselbrecht?   Register this Author

Register author
Christian Gisselbrecht

Christian Gisselbrecht

Publications by authors named "Christian Gisselbrecht"

Are you Christian Gisselbrecht?   Register this Author

100Publications

2529Reads

8Profile Views

An unmet need for long-term follow-up in Hodgkin's lymphoma?

Lancet Haematol 2018 10;5(10):e435-e436

Institut d'Hématologie, Hospital Saint Louis Paris, Paris 75010, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S2352-3026(18)30150-9DOI Listing
October 2018

How I manage patients with relapsed/refractory diffuse large B cell lymphoma.

Br J Haematol 2018 09 29;182(5):633-643. Epub 2018 May 29.

Cliniques universitaires UCL Saint-Luc, Brussels, Belgium.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.15412DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6175435PMC
September 2018

New perspectives in the therapeutic approach of peripheral T-cell lymphoma.

Curr Opin Oncol 2018 09;30(5):285-291

Hematology Department, Necker University Hospital, AP-HP, Paris Descartes University - Sorbonne Paris Cité, Paris, France.

View Article

Download full-text PDF

Source
http://Insights.ovid.com/crossref?an=00001622-900000000-9924
Publisher Site
http://dx.doi.org/10.1097/CCO.0000000000000469DOI Listing
September 2018

Positron Emission Tomography-Guided Therapy of Aggressive Non-Hodgkin Lymphoma: Standard of Care After the PETAL Study?

J Clin Oncol 2018 Sep 17:JCO1800498. Epub 2018 Sep 17.

Christian Gisselbrecht, Institut Hématologie, Hôpital Saint Louis, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.18.00498DOI Listing
September 2018

Is nivolumab an option for Hodgkin's lymphoma?

Lancet Oncol 2016 09 20;17(9):1183-4. Epub 2016 Jul 20.

Institut d'Hématologie Hopital Saint Louis, Paris 75010, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1470-2045(16)30220-0DOI Listing
September 2016

Decision-making in the management of adult classical Hodgkin's lymphoma: determining the optimal treatment.

Expert Rev Hematol 2015 Apr 29;8(2):205-16. Epub 2015 Jan 29.

Onco-Hematology Department, l'Archet Hospital, Nice, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/17474086.2015.995622DOI Listing
April 2015

The European medicines agency review of pomalidomide in combination with low-dose dexamethasone for the treatment of adult patients with multiple myeloma: summary of the scientific assessment of the committee for medicinal products for human use.

Oncologist 2015 Mar 11;20(3):329-34. Epub 2015 Feb 11.

European Medicines Agency, London, United Kingdom; Medicines and Healthcare Products Regulatory Agency, London, United Kingdom; Agencia Española de Medicamentos y Productos Sanitarios, Madrid, Spain; Läkemedelsverket, Medical Products Agency, Uppsala, Sweden; Hôpital Saint Louis, Paris, France; North Estonia Regional Hospital, Tallinn, Estonia.

View Article

Download full-text PDF

Source
http://theoncologist.alphamedpress.org/content/20/3/329.full
Web Search
http://theoncologist.alphamedpress.org/cgi/doi/10.1634/theon
Publisher Site
http://dx.doi.org/10.1634/theoncologist.2014-0073DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4350811PMC
March 2015

Futility of relapsed diffuse large B cell lymphoma transplantation?

Biol Blood Marrow Transplant 2014 Nov 1;20(11):1667-9. Epub 2014 Sep 1.

Institut d'Hématologie, Hopital Saint Louis, Paris, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2014.08.021DOI Listing
November 2014

Should we replace dexamethasone, cytarabine, and cisplatin for relapsed lymphoma?

J Clin Oncol 2014 Nov 29;32(31):3472-3. Epub 2014 Sep 29.

Hôpital Saint Louis Paris, Paris, France

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2014.56.6802DOI Listing
November 2014

The European medicines agency review of bosutinib for the treatment of adult patients with chronic myelogenous leukemia: summary of the scientific assessment of the committee for medicinal products for human use.

Oncologist 2014 Apr 25;19(4):421-5. Epub 2014 Mar 25.

European Medicines Agency, London, United Kingdom; Bundesinstitut für Arzneimittel und Medizinprodukte, Bonn, Germany; Agencia Española de Medicamentos y Productos Sanitarios, Servicio de Farmacología Clínica, Hospital Puerta de Hierro, Madrid, Spain; Läkemedelsverket, Medical Products Agency, Uppsala, Sweden; Hôpital Saint Louis, Paris, France; North Estonia Regional Hospital, Tallinn, Estonia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2013-0294DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3983815PMC
April 2014

Can we improve ABVD in Hodgkin's lymphoma?

Lancet Oncol 2013 Dec 15;14(13):1254-6. Epub 2013 Nov 15.

Hopital Saint Louis, 1 Avenue Claude Vellefaux, Paris 7510, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1470-2045(13)70528-XDOI Listing
December 2013

Ofatumumab in diffuse large B cell lymphoma?

Blood 2013 Jul;122(4):469-70

Hôpital Saint Louis Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2013-06-506048DOI Listing
July 2013

Is there any role for transplantation in the rituximab era for diffuse large B-cell lymphoma?

Hematology Am Soc Hematol Educ Program 2012 ;2012:410-6

Hospital Saint Louis, Paris Diderot University, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/asheducation-2012.1.410DOI Listing
June 2013

TP53 mutations and rituximab-CHOP.

Blood 2012 Nov;120(19):3867-9

Université Diderot Paris VII.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2012-09-455865DOI Listing
November 2012

Is Dose-Dense Therapy Effective Against DLBCL in the Era of Rituximab?

Oncology (Williston Park) 2012 May;26(5)

View Article

Download full-text PDF

Source
May 2012

Preface.

Best Pract Res Clin Haematol 2012 Mar;25(1):1-2

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.beha.2012.02.001DOI Listing
March 2012

Relapses, treatments and new drugs.

Best Pract Res Clin Haematol 2012 Mar 4;25(1):49-60. Epub 2012 Feb 4.

Service d'Onco-Hématologie, Hôpital de l'Archet, Nice, France.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S15216926120000
Publisher Site
http://dx.doi.org/10.1016/j.beha.2012.01.002DOI Listing
March 2012

Quality of life following treatment for B-cell lymphoma.

Expert Rev Pharmacoecon Outcomes Res 2011 Oct;11(5):523-32

Service d'Onco-Hématologie, Hôpital de l'Archet, Nice, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/erp.11.40DOI Listing
October 2011

Current approaches to the treatment of non-Hodgkin's lymphoma.

Hematol Rep 2011 Oct;3(3s):e3

Hôpital Saint Louis, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4081/hr.2011.s3.e3DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3269215PMC
October 2011

Stem cell transplantation for diffuse large B-cell lymphoma patients in the rituximab era.

Curr Opin Oncol 2011 Mar;23(2):209-13

Service d'Onco-Hématologie, Hôpital de l'Archet, Nice, France.

View Article

Download full-text PDF

Source
http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:land
Publisher Site
http://dx.doi.org/10.1097/CCO.0b013e328342b8adDOI Listing
March 2011

A revival: radioimmunotherapy in mucosa associated lymphoid tissue lymphoma.

Leuk Lymphoma 2011 Feb;52(2):159-60

Hospital Saint Louis, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/10428194.2010.550076DOI Listing
February 2011

Diversity in antibody-based approaches to non-Hodgkin lymphoma.

Leuk Lymphoma 2010 Aug;51 Suppl 1:20-7

Fred Hutchinson Cancer Research Center, Division of Oncology, University of Washington, Seattle, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/10428194.2010.500047DOI Listing
August 2010

Advances in the understanding and management of angioimmunoblastic T-cell lymphoma.

Br J Haematol 2010 Mar 4;148(5):673-89. Epub 2009 Dec 4.

Department of Pathology, CHU Sart Tilman, University of Liege, Institute of Pathology, Belgium.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1111/j.1365-2141.2009.08003.x
Publisher Site
http://dx.doi.org/10.1111/j.1365-2141.2009.08003.xDOI Listing
March 2010

Molecular signatures in T-cell lymphoma.

Blood 2010 Feb;115(5):919-20

University Diderot Paris 7, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2009-12-257014DOI Listing
February 2010

New directions in the therapeutic strategy to improve survival outcomes in patients with non-Hodgkin's lymphoma. Introduction.

Oncologist 2009 ;14 Suppl 2:1-3

Department of Nuclear Medicine, Centre Hospitalier Universitaire Vaudois, 1011 Lausanne, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2009-S2-1DOI Listing
January 2010

Harnessing the energy: development of radioimmunotherapy for patients with non-Hodgkin's lymphoma.

Oncologist 2009 ;14 Suppl 2:4-16

Section of Hematology, Rush University Medical Center/Rush University, 1725 West Harrison Street, Suite 834, Chicago, Illinois 60612, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2009-S2-4DOI Listing
January 2010

Expert opinions on positron emission tomography and computed tomography imaging in lymphoma.

Oncologist 2009 ;14 Suppl 2:30-40

Vanderbilt University Medical Center, Nashville, Tennessee, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2009-S2-30DOI Listing
January 2010

Radioimmunotherapy for stem cell transplantation in non-Hodgkin's lymphoma: in pursuit of a complete response.

Oncologist 2009 ;14 Suppl 2:41-51

Hôpital Saint-Louis, Hémato-oncologie, 1 Avenue Claude Vellefaux, Paris 75010, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2009-S2-41DOI Listing
January 2010

New directions in the therapeutic strategy to improve survival outcomes in patients with non-Hodgkin's lymphoma. Summary.

Oncologist 2009 ;14 Suppl 2:52-4

Department of Nuclear Medicine, Centre Hospitalier Universitaire Vaudois, 1011 Lausanne, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2009-S2-52DOI Listing
January 2010

Immuno-fluorescence in situ hybridization index predicts survival in patients with diffuse large B-cell lymphoma treated with R-CHOP: a GELA study.

J Clin Oncol 2009 Nov 28;27(33):5573-9. Epub 2009 Sep 28.

Assistance Publique-Hôpitaux de Paris, Groupe Henri Mondor-Albert Chenevier, L'Institut National de la Santé et de la Recherche Médicale, Unité 955, Institut Mondor de Recherche Biomédicale; Université Paris 12, Faculté de médecine, Créteil.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2009.22.7058DOI Listing
November 2009

Second-line treatment paradigms for diffuse large B-cell lymphomas.

Curr Oncol Rep 2009 Sep;11(5):386-93

Hôpital Saint Louis, Hemato-Oncologie, Institut Universitaire d'Hématologie, 1 Avenue Claude Vellefaux, 75010 Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11912-009-0052-0DOI Listing
September 2009

Should intra-cerebrospinal fluid prophylaxis be part of initial therapy for patients with non-Hodgkin lymphoma: what we know, and how we can find out more.

Semin Oncol 2009 Aug;36(4 Suppl 2):S25-34

Division of Clinical Neuro-oncology, Department of Neurology, University of Bonn, Bonn, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.seminoncol.2009.05.004DOI Listing
August 2009

Refining the treatment of follicular lymphoma.

Leuk Lymphoma 2008 ;49 Suppl 1:18-26

Department of Internal Medicine III, Klinikum Grosshadern, University of Munich, Munich, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428190802311409DOI Listing
January 2009

Secondary lymphomas of the central nervous system: risk, prophylaxis and treatment.

Leuk Lymphoma 2008 ;49 Suppl 1:52-8

Department of Medicine, University of Chicago, Chicago, IL 60637-1470, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428190802311458DOI Listing
January 2009

Use of rituximab in diffuse large B-cell lymphoma in the salvage setting.

Br J Haematol 2008 Dec 16;143(5):607-21. Epub 2008 Oct 16.

Hôpital Saint Louis, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1365-2141.2008.07383.xDOI Listing
December 2008

ZAP-70 protein expression and CD38 positivity in B-cell chronic lymphocytic leukemia.

Clin Adv Hematol Oncol 2008 Jan;6(1):55-63

Institut Universitaire d'Hématologie, Hopital St Louis, 75010 Paris, France.

View Article

Download full-text PDF

Source
January 2008

Autologous stem cell transplantation in lymphoma.

Semin Hematol 2007 Oct;44(4):234-45

Department of Hematology and Stem Cell Transplantation, ASKLEPIOS Klinik St. Georg, Hamburg, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.seminhematol.2007.08.007DOI Listing
October 2007

Modern management of non-Hodgkin lymphoma in HIV-infected patients.

Br J Haematol 2007 Mar 1;136(5):685-98. Epub 2006 Dec 1.

Groupe d'Etude des Lymphomes de l'Adulte, GELA, 1 av C Vellefaux, Paris, France.

View Article

Download full-text PDF

Source
http://www.hem-aids.ru/system/files/attachments/358/AIDS-NHL
Web Search
http://doi.wiley.com/10.1111/j.1365-2141.2006.06464.x
Publisher Site
http://dx.doi.org/10.1111/j.1365-2141.2006.06464.xDOI Listing
March 2007